HEADER TRANSFERASE 20-DEC-05 2FFR TITLE CRYSTALLOGRAPHIC STUDIES ON N-AZIDO-BETA-D-GLUCOPYRANOSYLAMINE, AN TITLE 2 INHIBITOR OF GLYCOGEN PHOSPHORYLASE: COMPARISON WITH N-ACETYL-BETA-D- TITLE 3 GLUCOPYRANOSYLAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOPHOSPHORYLASE; COMPND 5 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS GLYCOGENOLYSIS, INHIBITION, TYPE 2 DIABETES, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.I.PETSALAKIS,E.D.CHRYSINA,C.TIRAIDIS,T.HADJILOI,D.D.LEONIDAS, AUTHOR 2 N.G.OIKONOMAKOS,U.AICH,B.VARGHESE,D.LOGANATHAN REVDAT 6 30-AUG-23 2FFR 1 HETSYN REVDAT 5 29-JUL-20 2FFR 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 13-JUL-11 2FFR 1 VERSN REVDAT 3 24-FEB-09 2FFR 1 VERSN REVDAT 2 04-JUL-06 2FFR 1 JRNL REVDAT 1 20-JUN-06 2FFR 0 JRNL AUTH E.I.PETSALAKIS,E.D.CHRYSINA,C.TIRAIDIS,T.HADJILOI, JRNL AUTH 2 D.D.LEONIDAS,N.G.OIKONOMAKOS,U.AICH,B.VARGHESE,D.LOGANATHAN JRNL TITL CRYSTALLOGRAPHIC STUDIES ON JRNL TITL 2 N-AZIDOACETYL-BETA-D-GLUCOPYRANOSYLAMINE, AN INHIBITOR OF JRNL TITL 3 GLYCOGEN PHOSPHORYLASE: COMPARISON WITH JRNL TITL 4 N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE. JRNL REF BIOORG.MED.CHEM. V. 14 5316 2006 JRNL REFN ISSN 0968-0896 JRNL PMID 16616506 JRNL DOI 10.1016/J.BMC.2006.03.044 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.ANAGNOSTOU,M.N.KOSMOPOULOU,E.D.CHRYSINA,D.D.LEONIDAS, REMARK 1 AUTH 2 C.TIRAIDIS,T.HADJILOI,S.E.ZOGRAPHOS,Z.GYORGYDEAK,L.SOMSAK, REMARK 1 AUTH 3 T.DOCSA,P.GERGELY,F.N.KOLISIS,N.G.OIKONOMAKOS REMARK 1 TITL CRYSTALLOGRAPHIC STUDIES ON TWO BIOISOSTERIC ANALOGUES, REMARK 1 TITL 2 N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE AND REMARK 1 TITL 3 N-TRIFLUORACETYL-BETA-D-GLUCOPYRANOSYLAMINE, POTENT REMARK 1 TITL 4 INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE REMARK 1 REF BIOORG.MED.CHEM. V. 14 181 2006 REMARK 1 REFN ISSN 0968-0896 REMARK 1 PMID 16213146 REMARK 1 DOI 10.1016/J.BMC.2005.08.010 REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 3632333.310 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 62790 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3172 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.03 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9726 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE : 0.2690 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 517 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6590 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 358 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.31000 REMARK 3 B22 (A**2) : 3.31000 REMARK 3 B33 (A**2) : -6.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.850 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.260 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.140 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.300 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 46.10 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : PLP.PARAM REMARK 3 PARAMETER FILE 4 : DL6.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : PLP.TOP REMARK 3 TOPOLOGY FILE 4 : DL6.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 2FFR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000035825. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62829 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 29.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06900 REMARK 200 FOR THE DATA SET : 19.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.56300 REMARK 200 FOR SHELL : 4.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1WW2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MM BES BUFFER, 0.1 MM EDTA, 0.02% REMARK 280 NAN3, 3 MM DTT, PH 6.7, SMALL TUBES, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.08150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.31300 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.31300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.12225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.31300 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.31300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.04075 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.31300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.31300 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.12225 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.31300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.31300 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.04075 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.08150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DIMERIC GLYCOGEN PHOSPHORYLASE IS THE PHYSIOLOGIACALLY REMARK 300 ACTIVE SPECIES REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 6650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 116.16300 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 GLY A 260 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 ARG A 322 REMARK 465 VAL A 323 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 205 OD2 ASP A 217 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1281 O HOH A 1281 7556 1.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 15 -8.57 -56.22 REMARK 500 ALA A 19 65.32 -112.18 REMARK 500 ARG A 93 153.99 -44.88 REMARK 500 LEU A 131 40.11 -87.11 REMARK 500 TYR A 203 -135.62 61.65 REMARK 500 ARG A 234 52.75 32.02 REMARK 500 ASN A 253 10.16 55.49 REMARK 500 PRO A 281 28.76 -78.60 REMARK 500 SER A 313 44.55 -97.89 REMARK 500 PHE A 326 2.13 -62.33 REMARK 500 ASP A 339 -159.96 78.01 REMARK 500 THR A 466 -91.58 -121.48 REMARK 500 LEU A 492 -71.70 -146.79 REMARK 500 ASP A 514 68.46 -159.00 REMARK 500 LYS A 554 77.32 49.68 REMARK 500 LYS A 568 169.09 174.64 REMARK 500 SER A 674 -62.20 -144.59 REMARK 500 SER A 751 67.24 -151.40 REMARK 500 HIS A 768 59.88 -145.66 REMARK 500 ASN A 793 79.57 -119.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WW2 RELATED DB: PDB REMARK 900 THE SAME COMPLEX WITH N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE DBREF 2FFR A 12 836 UNP P00489 PYGM_RABIT 12 836 SEQADV 2FFR ARG A 322 UNP P00489 VAL 322 CONFLICT SEQADV 2FFR VAL A 323 UNP P00489 ARG 323 CONFLICT SEQRES 1 A 825 GLN ILE SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL SEQRES 2 A 825 THR GLU LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE SEQRES 3 A 825 THR LEU VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP SEQRES 4 A 825 TYR TYR PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU SEQRES 5 A 825 VAL GLY ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU SEQRES 6 A 825 LYS ASP PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE SEQRES 7 A 825 TYR MET GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU SEQRES 8 A 825 ALA LEU GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU SEQRES 9 A 825 GLY LEU ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP SEQRES 10 A 825 ALA GLY LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA SEQRES 11 A 825 CYS PHE LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA SEQRES 12 A 825 TYR GLY TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN SEQRES 13 A 825 GLN LYS ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP SEQRES 14 A 825 ASP TRP LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG SEQRES 15 A 825 PRO GLU PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL SEQRES 16 A 825 GLU HIS THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN SEQRES 17 A 825 VAL VAL LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY SEQRES 18 A 825 TYR ARG ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER SEQRES 19 A 825 ALA LYS ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN SEQRES 20 A 825 VAL GLY GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU SEQRES 21 A 825 ALA GLU ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN SEQRES 22 A 825 PHE PHE GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR SEQRES 23 A 825 PHE VAL VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG SEQRES 24 A 825 PHE LYS SER SER LYS PHE GLY CYS ARG ASP PRO ARG VAL SEQRES 25 A 825 THR ASN PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN SEQRES 26 A 825 LEU ASN ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU SEQRES 27 A 825 MET ARG VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP SEQRES 28 A 825 LYS ALA TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR SEQRES 29 A 825 ASN HIS THR VAL LEU PRO GLU ALA LEU GLU ARG TRP PRO SEQRES 30 A 825 VAL HIS LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN SEQRES 31 A 825 ILE ILE TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL SEQRES 32 A 825 ALA ALA ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG SEQRES 33 A 825 MET SER LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN SEQRES 34 A 825 MET ALA HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN SEQRES 35 A 825 GLY VAL ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR SEQRES 36 A 825 ILE PHE LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE SEQRES 37 A 825 GLN ASN LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU SEQRES 38 A 825 VAL LEU CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU SEQRES 39 A 825 ARG ILE GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU SEQRES 40 A 825 ARG LYS LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE SEQRES 41 A 825 ARG ASP VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS SEQRES 42 A 825 PHE ALA ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE SEQRES 43 A 825 ASN PRO ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE SEQRES 44 A 825 HIS GLU TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL SEQRES 45 A 825 ILE THR LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS SEQRES 46 A 825 PHE VAL VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA SEQRES 47 A 825 ALA PRO GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU SEQRES 48 A 825 ILE THR ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL SEQRES 49 A 825 VAL GLY ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR SEQRES 50 A 825 ARG VAL SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP SEQRES 51 A 825 LEU SER GLU GLN ILE SER THR ALA GLY THR GLU ALA SER SEQRES 52 A 825 GLY THR GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU SEQRES 53 A 825 THR ILE GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA SEQRES 54 A 825 GLU GLU ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET SEQRES 55 A 825 ARG VAL GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR SEQRES 56 A 825 ASN ALA GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG SEQRES 57 A 825 GLN ILE ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO SEQRES 58 A 825 LYS GLN PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU SEQRES 59 A 825 MET HIS HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU SEQRES 60 A 825 GLU TYR VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR SEQRES 61 A 825 LYS ASN PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN SEQRES 62 A 825 ILE ALA THR SER GLY LYS PHE SER SER ASP ARG THR ILE SEQRES 63 A 825 ALA GLN TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER SEQRES 64 A 825 ARG GLN ARG LEU PRO ALA HET PLP A 999 15 HET DL6 A 998 18 HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM DL6 N-(AZIDOACETYL)-BETA-D-GLUCOPYRANOSYLAMINE HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN DL6 2-AZIDO-N-((2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6- HETSYN 2 DL6 (HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YL)ACETAMIDE; N- HETSYN 3 DL6 AZIDOACETYL-BETA-D-GLUCOPYRANOSYLAMINE; N- HETSYN 4 DL6 (AZIDOACETYL)-BETA-D-GLUCOSYLAMINE; N-(AZIDOACETYL)-D- HETSYN 5 DL6 GLUCOSYLAMINE; N-(AZIDOACETYL)-GLUCOSYLAMINE FORMUL 2 PLP C8 H10 N O6 P FORMUL 3 DL6 C8 H14 N4 O6 FORMUL 4 HOH *358(H2 O) HELIX 1 1 ILE A 13 GLY A 17 5 5 HELIX 2 2 GLY A 20 THR A 38 1 19 HELIX 3 3 THR A 47 ASP A 78 1 32 HELIX 4 4 THR A 94 LEU A 102 1 9 HELIX 5 5 LEU A 104 LEU A 115 1 12 HELIX 6 6 ASP A 118 GLU A 124 1 7 HELIX 7 7 GLY A 134 LEU A 150 1 17 HELIX 8 8 PRO A 194 THR A 197 5 4 HELIX 9 9 GLY A 261 ASP A 268 1 8 HELIX 10 10 ASP A 268 ASN A 274 1 7 HELIX 11 11 ILE A 275 ARG A 277 5 3 HELIX 12 12 LYS A 289 SER A 313 1 25 HELIX 13 13 ASN A 325 ASP A 327 5 3 HELIX 14 14 ALA A 328 LYS A 332 1 5 HELIX 15 15 LEU A 344 LEU A 356 1 13 HELIX 16 16 ASP A 360 THR A 371 1 12 HELIX 17 17 LEU A 380 LEU A 384 5 5 HELIX 18 18 VAL A 389 LEU A 396 1 8 HELIX 19 19 LEU A 396 PHE A 418 1 23 HELIX 20 20 ASP A 421 SER A 429 1 9 HELIX 21 21 MET A 441 GLY A 448 1 8 HELIX 22 22 ALA A 456 THR A 466 1 11 HELIX 23 23 PHE A 468 GLU A 475 1 8 HELIX 24 24 ASN A 496 GLY A 508 1 13 HELIX 25 25 GLU A 509 VAL A 525 5 17 HELIX 26 26 ASP A 527 GLU A 552 1 26 HELIX 27 27 HIS A 571 LYS A 574 5 4 HELIX 28 28 ARG A 575 GLU A 593 1 19 HELIX 29 29 TYR A 613 ASN A 631 1 19 HELIX 30 30 ARG A 649 ILE A 657 1 9 HELIX 31 31 PRO A 658 ALA A 660 5 3 HELIX 32 32 THR A 676 ASN A 684 1 9 HELIX 33 33 ALA A 695 GLY A 704 1 10 HELIX 34 34 GLU A 705 PHE A 708 5 4 HELIX 35 35 ARG A 714 GLY A 725 1 12 HELIX 36 36 ASN A 727 ILE A 735 1 9 HELIX 37 37 ILE A 735 GLY A 748 1 14 HELIX 38 38 PHE A 758 HIS A 768 1 11 HELIX 39 39 VAL A 773 ALA A 775 5 3 HELIX 40 40 ASP A 776 LYS A 792 1 17 HELIX 41 41 ASN A 793 THR A 807 1 15 HELIX 42 42 SER A 808 PHE A 811 5 4 HELIX 43 43 SER A 812 ILE A 824 1 13 SHEET 1 A 3 LYS A 191 ALA A 192 0 SHEET 2 A 3 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 A 3 LEU A 198 PHE A 202 -1 N LEU A 198 O ALA A 223 SHEET 1 B 9 LYS A 191 ALA A 192 0 SHEET 2 B 9 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 B 9 VAL A 238 LYS A 247 -1 O SER A 245 N MET A 224 SHEET 4 B 9 ALA A 154 ILE A 159 1 N GLY A 156 O ARG A 242 SHEET 5 B 9 ARG A 81 LEU A 85 1 N ILE A 82 O TYR A 155 SHEET 6 B 9 VAL A 333 ASN A 338 1 O ALA A 334 N TYR A 83 SHEET 7 B 9 CYS A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 B 9 ALA A 451 GLY A 454 1 O ALA A 451 N TYR A 374 SHEET 9 B 9 PHE A 479 ASN A 481 1 O GLN A 480 N VAL A 452 SHEET 1 C 2 ASN A 167 CYS A 171 0 SHEET 2 C 2 TRP A 174 GLU A 178 -1 O MET A 176 N LYS A 169 SHEET 1 D 2 ARG A 205 HIS A 208 0 SHEET 2 D 2 ALA A 213 VAL A 216 -1 O VAL A 216 N ARG A 205 SHEET 1 E 3 ARG A 386 PRO A 388 0 SHEET 2 E 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 E 3 VAL A 431 GLU A 432 -1 N GLU A 432 O ARG A 438 SHEET 1 F 6 LEU A 640 LEU A 645 0 SHEET 2 F 6 ARG A 601 GLY A 606 1 N VAL A 603 O ARG A 641 SHEET 3 F 6 LEU A 562 VAL A 567 1 N ASP A 564 O MET A 604 SHEET 4 F 6 LEU A 662 GLN A 665 1 O LEU A 662 N PHE A 563 SHEET 5 F 6 LEU A 687 GLY A 690 1 O ILE A 689 N SER A 663 SHEET 6 F 6 PHE A 709 ILE A 710 1 O PHE A 709 N THR A 688 LINK NZ LYS A 680 C4A PLP A 999 1555 1555 1.35 CRYST1 128.626 128.626 116.163 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007774 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007774 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008609 0.00000